...
首页> 外文期刊>Aesthetic plastic surgery >Protocol for obtaining platelet-rich plasma (PRP), platelet-poor plasma (PPP), and thrombin for autologous use.
【24h】

Protocol for obtaining platelet-rich plasma (PRP), platelet-poor plasma (PPP), and thrombin for autologous use.

机译:获得自体使用的富血小板血浆(PRP),贫血小板血浆(PPP)和凝血酶的方案。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Plasma has been widely studied and used in many different situations to speed up healing with better tissue adherence and hemostasis. Research projects are now attempting to isolate platelet-rich plasma (PRP) and platelet-poor plasma (PPP), making better use of their properties, particularly during operations and for wounds that are slow to heal. In view of the wide diversity of industrial machines and extraction protocols, together with the variety of industrially produced biologic glues, this article suggests an option for obtaining PRP, PPP, and human thrombin for autologous use.A way of obtaining PRP, PPP, and thrombin is reproduced through a protocol defined and established by the authors. Autologous thrombin and plasma were obtained through the collection and successive centrifugation of ten whole blood samples, until the desired hemocomponents were isolated, followed by quantitative and qualitative analyses of the elements obtained.The mean platelet concentration obtained was 6.03 × 10(8) platelets/ml, with a mean thrombin concentration of 33.54 nM, both values compatible with reports in the literature when different protocols are applied.The protocol described is a good option for the preparation and application of PRP, PPP, and autologous thrombin, particularly as they can be obtained simultaneously, eliminating the possibilities of viral contamination and allergic reactions. Moreover, the cost of this procedure is low, it is easy to perform, and replicable. LEVEL OF EVIDENCE IV: This journal requires that authors assign a level of evidence to each article.
机译:对血浆进行了广泛的研究,并在许多不同的情况下使用它来加速愈合,并具有更好的组织粘附和止血作用。现在,研究项目正在尝试分离富含血小板的血浆(PRP)和贫血小板的血浆(PPP),以更好地利用它们的特性,尤其是在手术过程中以及愈合缓慢的伤口上。鉴于工业机器和提取协议的多样性,以及工业生产的生物胶的多样性,本文提出了一种用于自体使用的PRP,PPP和人类凝血酶的选择方法。凝血酶通过作者定义和建立的方案进行复制。通过收集并连续离心十个全血样品获得自体凝血酶和血浆,直到分离出所需的血液成分,然后对获得的元素进行定量和定性分析。获得的平均血小板浓度为6.03×10(8)血小板/毫升,平均凝血酶浓度为33.54 nM,当使用不同的协议时,这两个值均与文献报道兼容。所描述的协议是制备和应用PRP,PPP和自体凝血酶的良好选择,尤其是当它们可以同时获得,消除了病毒污染和过敏反应的可能性。而且,该过程的成本低,易于执行且可复制。证据级别IV:该期刊要求作者为每篇文章分配一定程度的证据。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号